- ISIN
- US59064R1095
- CUSIP
- 59064R109
- Sector
- Technology
- IPO Date
- Jan 25, 1995
Highlights
- Market Cap
- $516.87M
- Enterprise Value
- $489.94M
- EPS (TTM)
- $1.21
- PE Ratio
- 77.08
- PEG Ratio
- 0.49
- Total Revenue (TTM)
- $249.13M
- Gross Profit (TTM)
- $158.27M
- EBITDA (TTM)
- $36.60M
- Year Range
- $55.45 - $113.99
- Target Price
- $94.00
- ROA (TTM)
- 1.57%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MLAB Performance Chart
Mesa Laboratories, Inc. (MLAB) is up 19.2% since the beginning of the year. At $93 per share, MLAB is trading 18.2% below its 52-week high of $114. Investors who bought $1,000 worth of MLAB shares 5 years ago would now be looking at an investment worth $361.
Loading charts...
Returns By Period
Mesa Laboratories, Inc. (MLAB) has returned 19.15% so far this year and -1.96% over the past 12 months. Over the last ten years, MLAB has returned -2.10% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Mesa Laboratories, Inc.
- 1D
- -1.97%
- 1M
- -14.05%
- YTD
- 19.15%
- 6M
- 15.44%
- 1Y
- -1.96%
- 3Y*
- -9.25%
- 5Y*
- -18.42%
- 10Y*
- -2.10%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
MLAB Monthly Returns History
Based on dividend-adjusted daily data since Aug 18, 1995, MLAB's average daily return is +0.08%, while the average monthly return is +1.42%. At this rate, an investment would double in approximately 4.1 years.
Historically, 56% of months were positive and 44% were negative. The best month was Nov 2005 with a return of +39.2%, while the worst month was Sep 2023 at -26.7%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.
On a daily basis, MLAB closed higher 45% of trading days. The best single day was May 23, 2007 with a return of +22.6%, while the worst single day was Jun 3, 2019 at -25.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.33% | 22.82% | -8.44% | 13.10% | 2.18% | -8.62% | 19.15% | ||||||
| 2025 | 4.41% | 1.35% | -14.87% | -2.87% | -12.56% | -6.36% | -18.83% | -11.20% | -1.09% | 7.28% | 11.78% | -2.12% | -40.05% |
| 2024 | -12.55% | 19.35% | 0.49% | -3.33% | -9.65% | -9.33% | 31.98% | 16.88% | -2.86% | -12.18% | 2.86% | 12.57% | 26.56% |
| 2023 | 17.04% | -9.18% | -1.01% | -4.70% | -22.14% | -0.76% | 0.12% | 11.55% | -26.71% | -10.70% | -8.85% | 22.72% | -36.65% |
| 2022 | -13.34% | -10.14% | -0.18% | -16.18% | -1.98% | -2.54% | 4.57% | -19.80% | -17.58% | -6.12% | 28.08% | -1.75% | -49.18% |
| 2021 | -3.31% | -1.83% | -10.45% | 2.11% | -0.98% | 10.20% | 8.61% | -9.31% | 13.28% | 1.10% | 1.06% | 6.25% | 14.73% |
Benchmark Metrics
Mesa Laboratories, Inc. has an annualized alpha of 18.00%, beta of 0.42, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since August 18, 1995.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (74.37%) than losses (54.62%) - typical of diversified or defensive assets.
- Beta of 0.42 may look defensive, but with R2 of 0.03 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 18.00%
- Beta
- 0.42
- R²
- 0.03
- Upside Capture
- 74.37%
- Downside Capture
- 54.62%
Return for Risk
Risk / Return Rank
MLAB ranks 41 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Mesa Laboratories, Inc. (MLAB) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MLAB | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.06 | ||
| Sortino ratioReturn per unit of downside risk | -2.36 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.37 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.04 | 2.78 | -2.83 |
| Martin ratioReturn relative to average drawdown | -0.09 | 12.44 | -12.53 |
Dividends
Dividend History
Mesa Laboratories, Inc. provided a 0.69% dividend yield over the last twelve months, with an annual payout of $0.64 per share. The company has been increasing its dividends for 18 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 |
Dividend yield | 0.69% | 0.82% | 0.49% | 0.61% | 0.39% | 0.20% | 0.22% | 0.26% | 0.31% | 0.51% | 0.52% | 0.64% |
Monthly Dividends
The table displays the monthly dividend distributions for Mesa Laboratories, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.32 | ||||||
| 2025 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
| 2024 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
| 2023 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
| 2022 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
| 2021 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
Dividend Yield & Payout
Dividend Yield
Mesa Laboratories, Inc. has a dividend yield of 0.69%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Mesa Laboratories, Inc. has a payout ratio of 52.28%, which is quite average when compared to the overall market. This suggests that Mesa Laboratories, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Mesa Laboratories, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Mesa Laboratories, Inc. was 82.43%, occurring on Aug 5, 2025. The portfolio has not yet recovered.
The current Mesa Laboratories, Inc. drawdown is 71.27%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 bear market2025 | -82.43%Aug 2025 | 3y 7mo | — | 4y 5moDec 2021 - now |
2000 bear market2000 | -64.81%Feb 2000 | 3y 8mo | 3y 10mo | 7y 6moJun 1996 - Dec 2003 |
Financial crisis2007–2009 | -43.70%Mar 2009 | 1y 2mo | 9mo 9d | 1y 11moJan 2008 - Dec 2009 |
2014 bear market2014 | -41.25%Sep 2014 | 6mo 3d | 10mo | 1y 3moMar 2014 - Jul 2015 |
2016 bear market2016 | -34.53%Feb 2016 | 6mo 9d | 3mo 28d | 10mo 7dAug 2015 - Jun 2016 |
Drawdown Indicators
| MLAB | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.43% | -56.78% | -25.65% |
Max Drawdown (1Y)Largest decline over 1 year | -44.45% | -9.10% | -35.35% |
Max Drawdown (3Y)Largest decline over 3 years | -62.78% | -18.90% | -43.88% |
Max Drawdown (5Y)Largest decline over 5 years | -82.43% | -25.43% | -57.00% |
Max Drawdown (10Y)Largest decline over 10 years | -82.43% | -33.92% | -48.51% |
Current DrawdownCurrent decline from peak | -71.27% | -1.80% | -69.47% |
Average DrawdownAverage peak-to-trough decline | -25.47% | -10.71% | -14.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.72% | 2.03% | +20.69% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Mesa Laboratories, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Mesa Laboratories, Inc. is priced in the market compared to other companies in the Scientific & Technical Instruments industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for MLAB, comparing it with other companies in the Scientific & Technical Instruments industry. Currently, MLAB has a P/E ratio of 77.1. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for MLAB compared to other companies in the Scientific & Technical Instruments industry. MLAB currently has a PEG ratio of 0.5. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MLAB relative to other companies in the Scientific & Technical Instruments industry. Currently, MLAB has a P/S ratio of 2.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with MLAB
Add Mesa Laboratories, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MLAB